Article

Some Overweight Teens May Be at Risk for Weak Bones

New research shows that adolescents with risk factors such as pre-diabetes have less bone mass than their overweight but otherwise healthy peers.

Overweight adolescents already struggling with risk factors such as insulin resistance may need to add weak bones to their list of health concerns.

A study of 143 overweight 14-18 year olds showed that those with risk factors such as pre-diabetes and low levels of HDL cholesterol have less bone mass than their overweight but otherwise healthy peers, according to researchers at Georgia Health Sciences University’s Georgia Prevention Institute.

Other risk factors included high fat levels in the blood, higher blood pressure, and a larger waist size, said Norman Pollock, PhD, GHSU bone biologist and corresponding author of the study published in The Journal of Pediatrics. In fact, total body fat didn’t seem to impact bone mass; rather, it was visceral fat that seemed to increase the risk for weak bones.

“The more risk factors you have, the less bone mass you have,” Pollock said, noting that 62% of the overweight adolescents had at least one risk factor. It also indicates that the concept of ‘fit and fat’ may apply to the bones.

Study participants without one or more of these risk factors tended to get slightly more vigorous physical activity although none of the participants got the recommended 60-plus minutes of daily activity, Pollock said. Interestingly daily caloric intake for all study participants was in the optimal range.

“This says to kids and their parents that restricting calories is not the answer; we need to focus more on increasing vigorous physical activity,” Pollock said. Studies have shown that physical activity prompts bones to release a hormone called osteocalcin, which helps decrease fat-related risk factors such as insulin resistance.

“We are now beginning to respect the bones as an endocrine organ like we do now with fat and muscle,” Pollock noted. Activity also increases the number of bone-producing cells called osteoblasts.

The study appears to be the first analyzing bone-fat relationships and cardiometabolic risk factors in youth. Animal studies have shown, for example, that hypertensive mice have weaker bones.

Scientific literature on the impact of fat on bone health in children and adolescents has been confusing and even contradictory, wrote Heidi J. Kalkwarf, PhD, of Cincinnati Children’s Hospital Medical Center in an accompanying editorial in The Journal of Pediatrics. Pollock’s research adds the ‘additional twist’ that the presence of cardiometabolic risk factors indicates lower bone mass, she wrote.

The new study also raises more clinical questions, such as whether weight loss will help children improve bone mass and whether reduced mass during adolescence translates to increased fracture risk in adulthood, she wrote, noting that additional research is needed to assess long-term implications.

Peak bone mass is generally reached by early adulthood, so conditions that reduce optimal bone accumulation likely will lead to problems such as osteoporosis and fractures, the researchers reported.

Source: Georgia Health Sciences University

Related Videos
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Christine Frissora, MD | Credit: Weill Cornell
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Alice Cheng, MD: Exploring the Link Between Diabetes and Dementia | Image Credit: LinkedIn
Orly Vardeny, PharmD: Finerenone for Heart Failure with EF >40% in FINEARTS-HF | Image Credit: JACC Journals
© 2024 MJH Life Sciences

All rights reserved.